Cargando…
Comparison of the Reverse-Remodeling Effect of Pharmacological Soluble Guanylate Cyclase Activation With Pressure Unloading in Pathological Myocardial Left Ventricular Hypertrophy
Background: Pressure unloading induces the regression of left ventricular myocardial hypertrophy (LVH). Recent findings indicate that pharmacological activation of the soluble guanylate cyclase (sGC) – cyclic guanosine monophosphate (cGMP) pathway may also exert reverse-remodeling properties in the...
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6331535/ https://www.ncbi.nlm.nih.gov/pubmed/30670980 http://dx.doi.org/10.3389/fphys.2018.01869 |
_version_ | 1783387153432051712 |
---|---|
author | Ruppert, Mihály Korkmaz-Icöz, Sevil Li, Shiliang Brlecic, Paige Németh, Balázs Tamás Oláh, Attila Horváth, Eszter M. Veres, Gábor Pleger, Sven Grabe, Niels Merkely, Béla Karck, Matthias Radovits, Tamás Szabó, Gábor |
author_facet | Ruppert, Mihály Korkmaz-Icöz, Sevil Li, Shiliang Brlecic, Paige Németh, Balázs Tamás Oláh, Attila Horváth, Eszter M. Veres, Gábor Pleger, Sven Grabe, Niels Merkely, Béla Karck, Matthias Radovits, Tamás Szabó, Gábor |
author_sort | Ruppert, Mihály |
collection | PubMed |
description | Background: Pressure unloading induces the regression of left ventricular myocardial hypertrophy (LVH). Recent findings indicate that pharmacological activation of the soluble guanylate cyclase (sGC) – cyclic guanosine monophosphate (cGMP) pathway may also exert reverse-remodeling properties in the myocardium. Therefore, we aimed to investigate the effects of the sGC activator cinaciguat in a rat model of LVH and compare it to the “gold standard” pressure unloading therapy. Methods: Abdominal aortic banding was performed for 6 or 12 weeks. Sham operated animals served as controls. Pressure unloading was induced by removing the aortic constriction after week 6. The animals were treated from week 7 to 12, with 10 mg/kg/day cinaciguat or with placebo p.o., respectively. Cardiac function and morphology were assessed by left ventricular pressure-volume analysis and echocardiography. Additionally, key markers of myocardial hypertrophy, fibrosis, nitro-oxidative stress, apoptosis and cGMP signaling were analyzed. Results: Pressure unloading effectively reversed LVH, decreased collagen accumulation and provided protection against oxidative stress and apoptosis. Regression of LVH was also associated with a full recovery of cardiac function. In contrast, chronic activation of the sGC enzyme by cinaciguat at sustained pressure overload only slightly influenced pre-established hypertrophy. However, it led to increased PKG activity and had a significant impact on interstitial fibrosis, nitro-oxidative stress and apoptosis. Amelioration of the pathological structural alterations prevented the deterioration of LV systolic function (contractility and ejection fraction) and improved myocardial stiffness. Conclusion: Our results indicate that both cinaciguat treatment and pressure unloading evoked anti-remodeling effects and improved LV function, however in a differing manners. |
format | Online Article Text |
id | pubmed-6331535 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-63315352019-01-22 Comparison of the Reverse-Remodeling Effect of Pharmacological Soluble Guanylate Cyclase Activation With Pressure Unloading in Pathological Myocardial Left Ventricular Hypertrophy Ruppert, Mihály Korkmaz-Icöz, Sevil Li, Shiliang Brlecic, Paige Németh, Balázs Tamás Oláh, Attila Horváth, Eszter M. Veres, Gábor Pleger, Sven Grabe, Niels Merkely, Béla Karck, Matthias Radovits, Tamás Szabó, Gábor Front Physiol Physiology Background: Pressure unloading induces the regression of left ventricular myocardial hypertrophy (LVH). Recent findings indicate that pharmacological activation of the soluble guanylate cyclase (sGC) – cyclic guanosine monophosphate (cGMP) pathway may also exert reverse-remodeling properties in the myocardium. Therefore, we aimed to investigate the effects of the sGC activator cinaciguat in a rat model of LVH and compare it to the “gold standard” pressure unloading therapy. Methods: Abdominal aortic banding was performed for 6 or 12 weeks. Sham operated animals served as controls. Pressure unloading was induced by removing the aortic constriction after week 6. The animals were treated from week 7 to 12, with 10 mg/kg/day cinaciguat or with placebo p.o., respectively. Cardiac function and morphology were assessed by left ventricular pressure-volume analysis and echocardiography. Additionally, key markers of myocardial hypertrophy, fibrosis, nitro-oxidative stress, apoptosis and cGMP signaling were analyzed. Results: Pressure unloading effectively reversed LVH, decreased collagen accumulation and provided protection against oxidative stress and apoptosis. Regression of LVH was also associated with a full recovery of cardiac function. In contrast, chronic activation of the sGC enzyme by cinaciguat at sustained pressure overload only slightly influenced pre-established hypertrophy. However, it led to increased PKG activity and had a significant impact on interstitial fibrosis, nitro-oxidative stress and apoptosis. Amelioration of the pathological structural alterations prevented the deterioration of LV systolic function (contractility and ejection fraction) and improved myocardial stiffness. Conclusion: Our results indicate that both cinaciguat treatment and pressure unloading evoked anti-remodeling effects and improved LV function, however in a differing manners. Frontiers Media S.A. 2019-01-08 /pmc/articles/PMC6331535/ /pubmed/30670980 http://dx.doi.org/10.3389/fphys.2018.01869 Text en Copyright © 2019 Ruppert, Korkmaz-Icöz, Li, Brlecic, Németh, Oláh, Horváth, Veres, Pleger, Grabe, Merkely, Karck, Radovits and Szabó. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Physiology Ruppert, Mihály Korkmaz-Icöz, Sevil Li, Shiliang Brlecic, Paige Németh, Balázs Tamás Oláh, Attila Horváth, Eszter M. Veres, Gábor Pleger, Sven Grabe, Niels Merkely, Béla Karck, Matthias Radovits, Tamás Szabó, Gábor Comparison of the Reverse-Remodeling Effect of Pharmacological Soluble Guanylate Cyclase Activation With Pressure Unloading in Pathological Myocardial Left Ventricular Hypertrophy |
title | Comparison of the Reverse-Remodeling Effect of Pharmacological Soluble Guanylate Cyclase Activation With Pressure Unloading in Pathological Myocardial Left Ventricular Hypertrophy |
title_full | Comparison of the Reverse-Remodeling Effect of Pharmacological Soluble Guanylate Cyclase Activation With Pressure Unloading in Pathological Myocardial Left Ventricular Hypertrophy |
title_fullStr | Comparison of the Reverse-Remodeling Effect of Pharmacological Soluble Guanylate Cyclase Activation With Pressure Unloading in Pathological Myocardial Left Ventricular Hypertrophy |
title_full_unstemmed | Comparison of the Reverse-Remodeling Effect of Pharmacological Soluble Guanylate Cyclase Activation With Pressure Unloading in Pathological Myocardial Left Ventricular Hypertrophy |
title_short | Comparison of the Reverse-Remodeling Effect of Pharmacological Soluble Guanylate Cyclase Activation With Pressure Unloading in Pathological Myocardial Left Ventricular Hypertrophy |
title_sort | comparison of the reverse-remodeling effect of pharmacological soluble guanylate cyclase activation with pressure unloading in pathological myocardial left ventricular hypertrophy |
topic | Physiology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6331535/ https://www.ncbi.nlm.nih.gov/pubmed/30670980 http://dx.doi.org/10.3389/fphys.2018.01869 |
work_keys_str_mv | AT ruppertmihaly comparisonofthereverseremodelingeffectofpharmacologicalsolubleguanylatecyclaseactivationwithpressureunloadinginpathologicalmyocardialleftventricularhypertrophy AT korkmazicozsevil comparisonofthereverseremodelingeffectofpharmacologicalsolubleguanylatecyclaseactivationwithpressureunloadinginpathologicalmyocardialleftventricularhypertrophy AT lishiliang comparisonofthereverseremodelingeffectofpharmacologicalsolubleguanylatecyclaseactivationwithpressureunloadinginpathologicalmyocardialleftventricularhypertrophy AT brlecicpaige comparisonofthereverseremodelingeffectofpharmacologicalsolubleguanylatecyclaseactivationwithpressureunloadinginpathologicalmyocardialleftventricularhypertrophy AT nemethbalazstamas comparisonofthereverseremodelingeffectofpharmacologicalsolubleguanylatecyclaseactivationwithpressureunloadinginpathologicalmyocardialleftventricularhypertrophy AT olahattila comparisonofthereverseremodelingeffectofpharmacologicalsolubleguanylatecyclaseactivationwithpressureunloadinginpathologicalmyocardialleftventricularhypertrophy AT horvatheszterm comparisonofthereverseremodelingeffectofpharmacologicalsolubleguanylatecyclaseactivationwithpressureunloadinginpathologicalmyocardialleftventricularhypertrophy AT veresgabor comparisonofthereverseremodelingeffectofpharmacologicalsolubleguanylatecyclaseactivationwithpressureunloadinginpathologicalmyocardialleftventricularhypertrophy AT plegersven comparisonofthereverseremodelingeffectofpharmacologicalsolubleguanylatecyclaseactivationwithpressureunloadinginpathologicalmyocardialleftventricularhypertrophy AT grabeniels comparisonofthereverseremodelingeffectofpharmacologicalsolubleguanylatecyclaseactivationwithpressureunloadinginpathologicalmyocardialleftventricularhypertrophy AT merkelybela comparisonofthereverseremodelingeffectofpharmacologicalsolubleguanylatecyclaseactivationwithpressureunloadinginpathologicalmyocardialleftventricularhypertrophy AT karckmatthias comparisonofthereverseremodelingeffectofpharmacologicalsolubleguanylatecyclaseactivationwithpressureunloadinginpathologicalmyocardialleftventricularhypertrophy AT radovitstamas comparisonofthereverseremodelingeffectofpharmacologicalsolubleguanylatecyclaseactivationwithpressureunloadinginpathologicalmyocardialleftventricularhypertrophy AT szabogabor comparisonofthereverseremodelingeffectofpharmacologicalsolubleguanylatecyclaseactivationwithpressureunloadinginpathologicalmyocardialleftventricularhypertrophy |